Last reviewed · How we verify
Spinosad Creme Rinse
At a glance
| Generic name | Spinosad Creme Rinse |
|---|---|
| Sponsor | ParaPRO LLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Pilot Dose Ranging Study of Spinosad Creme Rinse (PHASE2)
- Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice (PHASE3)
- Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice (PHASE3)
- NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers (PHASE1)
- Phototoxicity Potential of NatrOVA Creme Rinse - 1% (PHASE1)
- A Dose Ranging Study of Different Strengths of Spinosad Topical Creme in Subjects With Pediculosis Capitis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Spinosad Creme Rinse CI brief — competitive landscape report
- Spinosad Creme Rinse updates RSS · CI watch RSS
- ParaPRO LLC portfolio CI